Revolutionary antibody discovery platform targets protein aggregation in Alzheimer`s and Parkinson`s, offering new ...

Singh Biotechnology (SBT), a privately held start-up company established in 2014 and based in Tampa Bay, Florida, focuses on the discovery and development of proprietary single domain antibodies ...

In diseases like Parkinson's and Alzheimer's, specific proteins misfold and clump together, forming toxic aggregates that ...

Single domain antibodies (sdAbs), also known as VHH antibodies or nanobodies™, are small antigen-binding fragments derived from camelids that have a single monomeric variable antibody domain. sdAbs ...

Originally derived from camelid heavy chain antibodies, single domain or VHH antibodies can bind epitopes that are inaccessible to conventional monoclonal antibodies due to their small size. Because ...

or single-domain antibody (VHH) format. Partners also have access to the IPA’s proprietary in-house disease and naïve human or llama phage libraries. • ImmunoPrecise’s affinity maturation ...

IBI Ag, a pioneering crop protection company developing a wide array of bio-insecticides with a lower ecological footprint, ...

In diseases like Parkinson's and Alzheimer's, specific proteins misfold and clump together, forming toxic aggregates that damage brain ...

Recombinant antibodies are invented antibodies formed by using recombinant DNA technology. While traditional monoclonal ...

JSKN003 is an anti-HER2 biparatopic ADC, which is developed inhouse with Alphamab's proprietary Glycan-specific conjugation platform. Compared with its ADC counterparts, JSKN003 demonstrated better ...

The partnership integrates Leveragen’s Singularity Sapiens Mouse platform with the T-cell engineering expertise of Moonlight Bio.